MedTrace Logo

Acute Effects of Zynamite® S in Cognitive Function and Mood

NCT07126717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-08-17

No results posted yet for this study

Summary

The present study sought to confirm the cognitive and mood benefits of a standardized soluble mango leaf extract, named as Zynamite® S. A placebo or a single dose of the botanical extract (100 mg) was administered and its acute effects on mental function and mood were evaluated before product intake, at 30 min, 3 h, and 5 h post-ingestion.

Conditions

  • Cognitive Performance
  • Mood

Interventions

DIETARY_SUPPLEMENT

Placebo

Food-grade maltodextrin

DIETARY_SUPPLEMENT

Zynamite® S

Water-soluble mango leaf extract standardized to 60% of mangiferin

Sponsors & Collaborators

  • University of Atlántico Medio

    collaborator UNKNOWN

  • Nektium Pharma SL

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2025-06-02
Completion
2025-06-09

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07126717 on ClinicalTrials.gov